Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological IndicationsEwan Hunter, Alexandre Akoulitchev, Ang Tick Suan et al.|Cancers|2023Cited by 14
Development and validation of blood-based diagnostic biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) using EpiSwitch® 3-dimensional genomic regulatory immuno-genetic profilingEwan Hunter, Dmitri Pchejetski, Heba Alshaker et al.|Journal of Translational Medicine|2025Cited by 14
3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcomeEwan Hunter, Alexandre Akoulitchev, Christina Koutsothanasi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 9
A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous PolypsEwan Hunter, Dmitri Pchejetski, Heba Alshaker et al.|Cancers|2025Cited by 5
Development and validation of blood-based prognostic biomarkers for severity of COVID disease outcome using EpiSwitch 3D genomic regulatory immuno-genetic profilingEwan Hunter, Alexandre Akoulitchev, Christina Koutsothanasi et al.|medRxiv|2021Cited by 4